Table 3. Integration of pharmacokinetic (in vivo plasma concentration) and pharmacodynamic (MPC determined in broth and serum) variables for florfenicol (mean and standard deviation).
Organism | Parameter | Units | Broth | Serum | ||
---|---|---|---|---|---|---|
Mean | SD | Mean | SD | |||
Pasteurella multocida | Cav0-48/MPC | 0.20 | 0.04 | 0.27 | 0.06 | |
Cav0-24/MPC | 0.28 | 0.10 | 0.39 | 0.13 | ||
Cav24-48/MPC | 0.13 | 0.05 | 0.17 | 0.07 | ||
Cmax/MPC | 0.55 | 0.50 | 0.76 | 0.69 | ||
T>MPC | h | 0 | 0 | |||
Actinobacillus pleuropneumoniae | Cav0-48/MPC | 0.29 | 0.06 | 0.23 | 0.05 | |
Cav0-24/MPC | 0.41 | 0.14 | 0.32 | 0.11 | ||
Cav24-48/MPC | 0.18 | 0.08 | 0.15 | 0.06 | ||
Cmax/MPC | 0.81 | 0.73 | 0.63 | 0.58 | ||
T>MPC | h | 0 | 0 |
Cav = average plasma concentration (μg/mL) for time periods 0–48, 0–24 and 24–48 h. Cmax = maximum plasma concentration (μg/mL); T>MPC = Time for which plasma concentration exceeded MPC (h). Individual animal Cav and Cmax obtained from 34 pigs divided by mean MPCs for six isolates of each species measured in broth and serum.